Sign In
Buy SGEN
$228.74
+0 (+0%)
At Close: Mar 12, 2024
Here's Why Seagen Stock Is Falling Today
11:40am, Thursday, 10'th Feb 2022
Investors aren't happy about disappointing forward guidance.
Seagen Inc. (SGEN) Q4 2021 Earnings Call Transcript
07:31am, Thursday, 10'th Feb 2022 The Motley Fool
SGEN earnings call for the period ending December 31, 2021.
Seagen Inc. (SGEN) Q4 2021 Earnings Call Transcript
07:31am, Thursday, 10'th Feb 2022 The Motley Fool
SGEN earnings call for the period ending December 31, 2021.
Seagen Inc. (SGEN) CEO Clay Siegall on Q4 2021 Results - Earnings Call Transcript
02:54am, Thursday, 10'th Feb 2022 Seeking Alpha
Seattle Genetics (SGEN) Reports Q4 Loss, Tops Revenue Estimates
10:15pm, Wednesday, 09'th Feb 2022 Zacks Investment Research
Seattle Genetics (SGEN) delivered earnings and revenue surprises of -20.25% and 6.55%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Seagen Inc. (SGEN) CEO Clay Siegall on Q4 2021 Results - Earnings Call Transcript
09:54pm, Wednesday, 09'th Feb 2022
Seagen Inc. (SGEN) CEO Clay Siegall on Q4 2021 Results - Earnings Call Transcript
Seagen sets 2022 guidance below expectations despite Q4 revenue beat
09:30pm, Wednesday, 09'th Feb 2022 Seeking Alpha
Seagen (SGEN) is trading ~7% lower in the post-market on Wednesday after the biotech posted a mixed performance with its Q4 2021 financials and projected its 2022 outlook below the…
Seattle Genetics (SGEN) Reports Q4 Loss, Tops Revenue Estimates
06:24pm, Wednesday, 09'th Feb 2022
Seattle Genetics (SGEN) delivered earnings and revenue surprises of -20.25% and 6.55%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In
01:31pm, Wednesday, 09'th Feb 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Humanigen Announces Agreement With French CDMO For Fill And Finish Services For Lenzilumab
Humanigen,
Seattle Genetics Q4 2021 Earnings Preview (NASDAQ:SGEN)
10:35pm, Tuesday, 08'th Feb 2022 Seeking Alpha
Seattle Genetics (NASDAQ:SGEN) is scheduled to announce Q4 earnings results on Wednesday, February 9th, after market close.The consensus EPS Estimate is -$0.87 (-196.7% Y/Y) and…
A Peek Into The Markets: US Stock Futures Down; Crude Oil Falls Over 1%
10:22am, Monday, 07'th Feb 2022 Benzinga
Pre-open movers
U.S. stock futures traded lower in early pre-market trade after the Nasdaq jumped more than 200 points in the previous session. Investors are awaiting earnings results from Tyson Food
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
01:22pm, Sunday, 06'th Feb 2022 Benzinga
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some bi
Seagen''s Adcetris combo improves survival of blood cancer patients in phase 3 trial
05:50pm, Thursday, 03'rd Feb 2022 Seeking Alpha
Seagen <> said its medicine Adcetris (brentuximab vedotin) in combination with chemotherapy showed statistically significant improvement in overall survival in patients with
Earnings Preview: Seattle Genetics (SGEN) Q4 Earnings Expected to Decline
08:01pm, Wednesday, 02'nd Feb 2022 Zacks Investment Research
Seattle Genetics (SGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2022
03:28pm, Monday, 31'st Jan 2022 Benzinga
Upgrades
UBS upgraded the previous rating for Align Technology Inc (NASDAQ:ALGN) from Neutral to Buy. For the third quarter, Align Tech had an EPS of $2.87, compared to year-ago quarter EPS of $2.25.
